13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001104659-23-020417
Total Value
$372.1M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CINCOR PHARMA INC | 17240Y109 | 4,937,646 | $60.7M | 16.31% |
| 2 | ENTRADA THERAPEUTICS INC | TRDA | 4,408,379 | $59.6M | 16.02% |
| 3 | VOR BIOPHARMA INC | VOR | 6,361,723 | $42.3M | 11.37% |
| 4 | RALLYBIO CORP | RLYB | 3,730,724 | $24.5M | 6.59% |
| 5 | IDEAYA BIOSCIENCES INC | IDYA | 1,196,298 | $21.7M | 5.84% |
| 6 | PEAR THERAPEUTICS INC | 704723105 | 16,744,113 | $19.8M | 5.31% |
| 7 | SCPHARMACEUTICALS INC | 810648105 | 2,734,852 | $19.6M | 5.27% |
| 8 | CRINETICS PHARMACEUTICALS IN | CRNX | 862,286 | $15.8M | 4.24% |
| 9 | AVIDITY BIOSCIENCES INC | 05370A108 | 665,555 | $14.8M | 3.97% |
| 10 | DISC MEDICINE INC | IRON | 588,442 | $11.7M | 3.15% |
| 11 | ANAPTYSBIO INC | ANABV | 357,733 | $11.1M | 2.98% |
| 12 | ARVINAS INC | ARVN | 320,000 | $10.9M | 2.94% |
| 13 | IMPEL NEUROPHARMA INC | 45258K109 | 2,884,791 | $10.8M | 2.91% |
| 14 | COGENT BIOSCIENCES INC | COGT | 790,440 | $9.1M | 2.46% |
| 15 | VIRIDIAN THERAPEUTICS INC | VRDN | 300,000 | $8.8M | 2.35% |
| 16 | IVERIC BIO INC | 46583P102 | 384,626 | $8.2M | 2.21% |
| 17 | PHARVARIS N V | PHVS | 587,600 | $6.6M | 1.78% |
| 18 | JANUX THERAPEUTICS INC | JANX | 446,266 | $5.9M | 1.58% |
| 19 | HOMOLOGY MEDICINES INC | 438083107 | 4,535,919 | $5.7M | 1.54% |
| 20 | FIBROGEN INC | 31572Q808 | 225,583 | $3.6M | 0.97% |
| 21 | CIDARA THERAPEUTICS INC | 171757107 | 1,134,511 | $858,031 | 0.23% |